Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 5 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
Inside the fallout of the Dianna Russini and Mike Vrabel photos
- 10 hours ago
Rahm unbothered by LIV drama, leads in Mexico
- 10 hours ago
Democrats are winning the redistricting war — for now, anyway
- 9 hours ago
SBP repays deposit of $1b to Abu Dhabi Fund for Development
- 2 hours ago
22 terrorists neutralised in KP's Khyber district: ISPR
- an hour ago
The wide-ranging fallout from the Supreme Court’s new terrorism decision, explained
- 9 hours ago
Gay, Hend share lead in Senior PGA Championship
- 10 hours ago
Apple Sports now lets you follow scores in a CarPlay widget
- 2 hours ago
Fitzpatrick rides 'lucky' shot to RBC Heritage lead
- 10 hours ago
LIV CEO: League has backing to finish '26 season
- 10 hours ago
Ikea and Samsung promise glitch-free SmartThings integration
- 2 hours ago
John Ternus is taking over from Tim Cook as Apple’s CEO
- 2 hours ago
You May Like
Trending
